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Summary 
Interleukin-2 receptor a chain (IL-2Ra) expression oc- 
curs at specific stages of early T and 6 lymphocyte 
development and is induced upon activation of mature 
lymphocytes. Young mice that lack IL-2Ra have pheno- 
typically normal development of T and B cells. How- 
ever, as adults, these mice develop massive enlarge- 
ment of peripheral lymphoid organs associated with 
polyclonal T and B cell expansion, which, for T cells, 
is correlated with impaired activation-induced cell 
death in vivo. Older IL-2Ra-deficient mice also develop 
autoimmune disorders, including hemolytic anemia 
and inflammatory bowel disease. Thus, IL-2Ra is es- 
sential for regulation of both the size and content of 
the peripheral lymphoid compartment, probably by in- 
fluencing the balance between clonal expansion and 
cell death following lymphocyte activation. 
Introduction 
Interleukin-2 (IL-2) has broad activities in the immune sys- 
tem, enhancing cellular proliferation by acting as a cell 
cycle progression factor, as well as promoting functional 
differentiation of T and B cell lineage cells (Smith, 1988; 
Tigges et al., 1989). IL-2 is produced by a subset of acti- 
vated CD4+ T cells, and has been regarded as an amplifier 
of immune stimuli (Paul and Seder, 1994; Swain, 1991). 
However, conflicting data exist regarding the role of IL-2 
in vivo. Immune responses are relatively normal in mice 
that lack IL-2 (Schorle et al., 1991; Kundig et al., 1993). 
Moreover, under some circumstances IL-2 can promote T 
cell death in response to activation, suggesting a negative 
regulatory role in maintaining the balance between the 
expansion and deletion of lymphocyte clones in response 
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to antigenic stimuli (Lenardo, 1991; Critchfield et al., 
1994). 
The high affinity IL-2 receptor is comprised of three com- 
ponent chains, IL-2Ra (~55, CD25, Tat antigen), IL9Rf3 
(~75, CD122), and IL-2Ry (~65) (Smith, 1988; Waldmann, 
1991; Leonard et al., 1994). IL-2Rf3 and IL9Ry are present 
constitutively in resting lymphocytes (Siegel et al., 1987; 
Kondo et al., 1994). In contrast, IL-2Ra is expressed only 
following activation (Smith, 1988; Waldmann, 1991; Tani- 
guchi and Minami, 1993). Together, the IL9R8and IL-2Rr 
chains form a low affinity IL-2 receptor (dissociation con- 
stant, Kd = 10m9 M), which is sufficient to effect signal 
transduction upon ligation; however, the physiologic role 
of this low affinity IL-2R is not known (Nakamura et al., 
1994; Nelson et al., 1994). While the IL-2Ra chain is inca- 
pable of independently generating intracellular signals, its 
association with the IL-2Rp and IL-2Rr chains forms the 
high affinity IL-2 receptor (Kd = 10-l’ M) (Teshigawara et 
al., 1987; Wang and Smith, 1987). Therefore, one function 
of IL-2Ra is to regulate the sensitivity of activated lympho- 
cytes to IL-2. 
Both ILQR6 and IL-2Rr are shared components of other 
lymphokine receptors. IL4Rf3 is part of the IL-15 receptor 
(Grabstein et al., 1994) and appears to be required for 
peripheral immune regulation, since mice lacking this 
chain exhibit T and B cell activation in vivo as well as 
autoimmunity (Suzuki et al., 1995). IL-2Ry is shared 
among receptors for IL-4, IL-7, IL-g, and IL-15 (Leonard 
etal., 1994; Kimuraetal., 1995;Giriet al., 1994). Mutations 
in the IL9Ry gene result in X-linked severe combined im- 
mune deficiency in humans and a similar severe defect 
in lymphoid development in mice, presumably owing to 
defects in several of these signaling pathways (Leonard 
et al., 1994; DiSanto et al., 1995; Cao et al., 1995). The 
IL-2Ra chain has not been found in association with any 
other receptors and is not known to interact with any ligand 
other than IL-2. Yet, IL-2Ra is specifically expressed dur- 
ing early lymphocyte development in mice, both at the 
CD4-CD8-CD3- thymocyte stage, as well as on small bone 
marrow pre-B cells (Rothenberg, 1992; Chen et al., 1994; 
Rolink et al., 1994). However, IL-2 has no known role at 
these early stages, inasmuch as mice that lack IL-2 have 
no apparent defect in the development of T and B cells 
(Schorle et al., 1991). Hence, the potential function of IL- 
2Ra in lymphocyte development remains speculative. 
To examine directly the function of IL-2Ra in lymphocyte 
development and function, we generated mice homozy- 
gous for a null mutation of the IL-2Ra gene. The phenotype 
of these mice suggests that the predominant role of the 
IL-2 receptor in vivo is to deliver negative regulatory sig- 
nals within the peripheral lymphoid compartment. 
Results 
Generation of Mice that Lack IL-2Ra 
Homologous recombination was used to create a mutation 
in the IL-2Ra gene in embryonic stem cells. A targeting 
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vector was constructed by replacing a 5.5 kb segment of 
the IL-2Ra gene containing exons 2 and 3, which encode 
the binding site for IL-2 (Kuo et al., 1988), with a neomycin 
resistance gene driven by the PGK promoter (Figure 1A). 
Two independent embryonic stem (ES) cell clones con- 
taining the mutated IL-2Ra allele were obtained, and each 
transmitted the mutation efficiently into the mouse germ- 
line. Heterozygotes carrying the IL-2Ra mutation were in- 
terbred, and offspring were genotyped by Southern blot 
analysis of tail DNA (Figure 1 B). Wild-type, heterozygous, 
and homozygous mutant mice were obtained with ex- 
pected mendelian frequency. Young IL-2Ra-‘- mice were 
healthy and indistinguishable from wild-type littermates. 
The progeny of each ES cell clone gave identical pheno- 
types in the studies described here. 
IL-2Ra Is Not Essential for T and B 
Cell Development 
At the age of 4 weeks, lymphoid development was ana- 
lyzed in the thymus and bone marrow by expression of 
A. 6. 
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Figure 1. Targeted Mutation of the IL-2Ra 
Gene in ES Cells 
(A) Partial genomic map (top) of the murine IL- 
2Ru locus, with axons numbered to correspond 
with the human gene (Leonard et al., 1985). A 
targeting vector (middle) replaced exons 2 and 
3 with a PGK-neo cassette. The structure of 
the targeted allele following homologous re- 
combination is also depicted (bottom). Detec- 
tion of the targeted allele relied on the introduc- 
tion of an EcoRV restriction site polymorphism, 
which could be identified using Probe A. 
(6) Genotypic analysis of offspring of mice het- 
erozygous for the targeted mutation of IL-2Ra. 
Tail DNA was digested with EcoRV and ana- 
lyzed by Southern blot. Symbols represent wild 
type (+I+), heterozygous (+I-). and homozy- 
gous mutant (-I-). 
CD4 and CD8, and of immunoglobulin M (IgM), 8220, and 
CD43, respectively. No differences were noted in develop- 
mental subpopulations defined by these markers between 
IL-2Ra-‘- mice and wild-type littermates (Figure 2A). In 
addition, lymph node, splenic, and circulating populations 
of CD4’ and CD8+ T cells and lgM’B220’ B cells, as well 
as peritoneal CD5+ B cells, were present in normal propor- 
tions in young IL-2Ra+ mice (data not shown). The ex- 
pression of IL-2Ra on CD4-CD8CD3- early thymocytes 
was examined using an antibody that recognizes an epi- 
tope distinct from that encoded by the deleted portion of 
the gene (Lorenzo et al., 1991). While the majority of cells 
in this subset had high levels of IL-2Ra in wild-type ani- 
mals, expression was abrogated in IL-2Ra+ mice (Figure 
28). In heterozygotes, IL-2Ra levels were reduced approx- 
imately e-fold, indicating a gene dosage effect. IL-2Ra ex- 
pression was similarly absent from the B220+lgM- bone 
marrow fraction in mutant mice (data not shown). Northern 
blot analysis of RNA derived from concanavalin A (Con-A)- 
stimulated lymph node T cells demonstrated readily de- 
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Figure 2. Analysis of Lymphoid Development 
in Thymus and Bone Marrow of 4-weekold 
Mice 
(A) Flow cytometric analysis of thymic and bone 
marrow lymphocytes stained with FITC- and 
PE-conjugated monoclonal antibodies to the 
markers indicated. 
(B) Three-color flow cytometric analysis of IL- 
2Ra surface expression on thymocytes stained 
with FITC-anti-IL-2Ra (clone 7D4), PE-anti- 
CD4 and PE-anti-CD& and biotin-anti-CD3s, 
biotin-anti-8220, biotin-anti-Gr-1, and biotin- 
anti-Mac-l, followed bystreptavidin-cychrome. 
Electronic gating was used to exclude PE and 
cychrome-positive cells. Fluorescence profile 
of wild-type CD4’CDB’ thymocytes, which are 
IL-2Ra negative (Rothenberg, 1992) is shown 
as a control. 
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tectable expression of IL-2Ra transcripts in wild-type mice 
but only low levels of an aberrant-sized (larger) transcript 
in IL-2Ra-I- mice, further indicating that the targeted muta- 
tion in the IL-2Ra gene generated a null allele (data not 
shown). These data indicate that expression of the IL-2Ra 
chain is not essential for T and B cell development. 
Massive Lymphoid Expansion in Adult 
IL-SRa-Deficient Mice 
Between 4 and 6 weeks of age, IL-2Ra-deficient mice de- 
veloped massive enlargement of lymph nodes and spleen 
(Figure 3A). The increased size of these organs was due 
to expansion of lymphocytes (Figure 3B), which consisted 
of otherwise normal proportions of CD4+ and CD8+ T cell 
subsets and lgM+B220+ B cells (Figure 3C). Histologic and 
immunohistologic examination of lymph nodes, spleen, 
and gut-associated lymphoid tissue in IL-2Ra-‘- mice re- 
vealed a marked expansion of lymphoid tissue in all of 
these sites, with preservation of overall architectural orga- 
nization of T and B cell areas (D. M. W. and J. A. F., 
unpublished data). Southern blot analysis using probes 
for T cell receptor and IgH loci demonstrated that the 
lymphoid expansion in mutant mice was polyclonal (data 
not shown). 
Peripheral lymphocytes from IL-2Ra mutant mice were 
further analyzed for evidence of activation in vivo. T cells 
were on average slightly larger than wild-type lymphocytes 
by forward light scatter profile, but the proportion of 
lymphoblasts identified by forward and 90° scatter criteria 
was not increased (Figure 4). DNA content analysis of 
peripheral lymphocytes derived from wild-type or IL-2Ra- 
deficient mice did not reveal a difference in the fraction 
of either T or B cells that were actively cycling. (D. M. W. 
and F. W. A., unpublished data). The fraction of lymph 
node T cells expressing the early activation marker CD69 
was not significantly increased in IL-2Ra mutant lympho- 
cytes (8.7% + 2.2%) compared with wild type (5.9% f 
1 .l O/O). However, in contrast with wild-type mice, the major- 
ity of peripheral T cells from IL-2Ra-‘- mice demonstrated 
high level expression of CD44 (Figure 4). The CD44”’ phe- 
notype is indicative of previous activation and is a marker 
for memory cells (MacDonald et al., 1990). These results 
indicate that while most T cells bear phenotypic signs of 
past antigenic encounter, there was no discernible steady- 
state increase in acute cellular activation and proliferation 
in vivo. 
Reduced Proliferative Responses in IL-2Ra-‘- 
T Cells In Vitro 
The responses of IL-2Ra-‘- T cells to activation in vitro 
were evaluated with thymidine incorporation assays using 
purified lymph node T cells. Proliferation to optimal doses 
of anti-CD3 was reduced approximately 1 O-fold in IL-2Ra-‘- 
Tcells (Table 1). As expected, signal transduction through 
the TCR-CD3 complex was intact in the absence of IL-2Ra, 
since the early activation marker CD69 was up-regulated 
normally after exposure to anti-CD3 for 12 hr (data not 
shown). Sensitivity to exogenous IL-2 was examined by 
stimulation with a low dose of anti-CDS, which is adequate 
to prime cells for IL-2induced proliferation but insufficient 
to generate endogenous IL-2 production (Meuer et al., 
1984; Smith, 1988). Under these conditions, T cells from 
IL-2Ra mutant mice were unresponsive to doses of IL-2 as 
high as 100 U/ml, while wild-type T cells had a detectable 
response to IL-2 doses as low as 3 U/ml. Both wild-type and 
IL-2Ra mutant T cells were able to proliferate vigorously in 
response to IL-2 at 300-1000 U/ml. Thus, the defective 
proliferative responses to CD3 signaling observed in IL-2Ra 
mutant T cells are consistent with reduced autocrine IL-2 
signaling in the absence of a high affinity IL-2 receptor 
(Meuer et al., 1984; Smith, 1988; Wang and Smith, 1987). 
Together with the phenotypic studies above, these results 
suggest that the lymphoid enlargement observed in IL- 
2Ra+ mice was not due primarily to exaggerated prolifer- 
ation. 
Peripheral Deletion of SEB-Reactive T Cells Is 
Impaired in IL-2Ra-Deficient Mice 
An alternative explanation for the expanded lymphoid 
compartment in IL-2Ra mutant mice might involve adefect 
in the regulation of cell death in response to activation. 
Activation-induced Tcell death can be stimulated following 
injection of bacterial superantigens, such as staphylococ- 
cal enterotoxin B (SEB) (Kawabe and Ochi, 1991), and 
can serve as a probe for the integrity of this process in 
vivo (Lenardo, 1991). In control mice, SEB immunization 
resulted in the elimination of approximately 40% of super- 
antigen reactive V88+ T cells, while nonreactive Vj36’ T 
cells showed a small compensatory increase in represen- 
tation (Figure 5). The deletion of V88+ T cells was substan- 
tially impaired in IL-2Ra-‘- mice, which exhibited only a 
10% reduction. In three additional independent experi- 
ments, control mice exhibited 35%-500/o deletion of V68+ 
cells, while IL-2Ra-‘- mice showed a lo%-20% reduction 
in these cells. Such a defect in activation-induced cell 
death may potentially account for the abnormal accumula- 
tion of T lymphocytes in IL-2Ra-deficient mice. 
B Cell Function Is Deregulated in Mice 
Lacking IL-2Ra 
There were marked elevations in serum immunoglobulins 
in IL-2Ra-‘- mice. This increase affected the IgGl, IgG2a, 
lgG2b, and IgA isotypes, for which mean serum concentra- 
tions were elevated 5-to 30-fold over wild type (Figure 6). 
The levels of IgM and lgG3 were normal in mutant mice. 
Proliferation of splenic B cells in response to lipopolysac- 
charide (LPS) and combined LPS and IL-4 stimulation 
were unaffected by the IL-2Ra mutation (data not shown). 
In addition, in vitro assays of immunoglobulin isotype 
switching in response to these stimuli were normal in IL- 
2Ra-‘- spleen cells (D. M. W. and F. W. A., unpublished 
data). Thus, the selective elevation of switched isotypes 
in IL-2Ra-‘- mice may be a secondary effect of the T cell 
abnormalities in these mice. 
Anemia and Inflammatory Bowel Disease in Mice 
Lacking IL-2Ra 
With age, manifestations of autoimmunity emerged in IL- 
2Ra-deficient mice. Between 8 and 20 weeks, approxi- 
mately 25% of IL-2Ra mutant mice died with a severe 
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Figure 3. Enlargement of Lymphoid Organs in 
IL-PRu-Deficient Mice 
(A) Peripheral lymph nodes and spleen from 
7-week-old IL-2Ra-‘- mouse (left) next to those 
from a wild-type littermate (right). 
(B) Cell counts from peripheral lymph nodes 
(cervical, axillary, and inguinal) and spleen 
from wild-type (+I+), heterozygous (+I-), and 
IL-2Ra-deficient (-I-) mice. Symbols repre- 
sent individual mice. 
cl 
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(C) Flow cytometric analysis of lymph node and 
splenic lymphocyte populations from wild-type 
(+/+) and IL-2Ra mutant (-I-) mice. Cell sus- 
pensions were stained with either antibodies 
to CDB-FITC and CD4-PE or IgM-FITC and 
B220-PE. 
CD8 + - 
IgM + - -- 
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Figure 4. Phenotypic Analysis of Lymph Node 
T Cells from Wild-Type (+I+) and IL-2Ra Mu- 
tant (-I-) Mice 
Lymph node cells were stained with antibodies 
to CD3-FITC and CD44-biotin. followed by 
streptavidin-cychrome. Data were gated to in- 
clude CD3’ cells. Histograms show profiles for 
forward light scatter (FSC, linear scale) and 
CD44 expression (log scale). 
- FSC ‘-+ - CD44 ___) 
anemia(hematocrit 9-l 2 in three mice sacrificed pretermi- 
nally, versus 45-48 in wild-type littermates). Blood films 
demonstrated characteristic morphologic changes of anti- 
body-mediated extravascular destruction, including retic- 
ulocytes constituting up to 70% of red cells (normal 5%- 
8%), and severe irregularities of cell size and shape, 
including numerous small spherical cells. Spleens from 
anemic mice contained a marked expansion of erythroid 
elements (data not shown). Starting at 12-16 weeks of 
age, the majority of surviving IL-2Ra-‘- mice began to de- 
velop an inflammatory bowel disease, characterized by 
diarrhea and wasting. At necropsy, there was severe 
bowel inflammation, which was confined to the colon. His- 
tological examination revealed marked thickening of the 
mucosa, with areas of ulceration, infiltration of lympho- 
cytes as well as neutrophils, inflammation of crypts with 
crypt abscesses, and epithelial destruction (Figure 7). 
Signs of mucosal regeneration with crypt branching also 
were evident. This histologic appearance is similar to that 
of ulcerative colitis in humans. These manifestations of 
acquired autoreactivity suggest that in addition to influenc- 
ing the overall size of the peripheral lymphoid compart- 
ment, IL-2Ra is involved in regulating its specific content. 
Discussion 
Role of IL-2Ra in T and B Cell Development 
IL-2 receptor signals have been implicated in the expan- 
sion and differentiation of early thymocytes. Several stud- 
ies have shown proliferative effects of IL-2 on thymocytes 
in vitro(Carding et al., 1991; Zuniga-Pflucker et al., 1990). 
Moreover, antibody blockade of IL-2Ra in vivo inhibits T 
cell development in fetuses in utero (Tentori et al., 1988) 
as well as during thymic regeneration following suble- 
thal irradiation (Zuniga-Pflucker and Kruisbeek, 1990). 
The expression pattern of IL-2Ra, which is specific for 
CD4CDE-CD3- thymocytes and IgM-B220+CD43- pre-B 
cells further suggested the importance of this pathway in 
lymphocyte development (Chen et al., 1994; Rolink et al., 
1994; Rothenberg, 1992). Yet, mice that lack IL-2 have 
no apparent defect in T or B cell development (Schorle 
et al., 1991). One possible explanation for this apparent 
discrepancy would invoke an additional ligand for IL-2Ra, 
which is required during lymphoid development. Our stud- 
ies do not support such an interpretation, and demonstrate 
that IL-2Ra is not required for the generation of mature T 
and 6 cells. We have not ruled out a role for IL-2Ra in 
Table 1. Response of Purified LN T Cells to Anti-CDS, with or without Exogenous Murine IL-2 
CPM 
~~ 
Genotype Medium Anti-CD3 10 Anti-CD3 0.3 Anti-CD3 0.3 + IL-2 40 U/ml Anti-CD3 0.3 + IL-2 1000 U/ml 
+/+ 149 101,653 140 0,245 25,605 
+/+ 148 119,100 140 12,184 34,401 
I- 142 5,539 109 222 36,794 
-/- 121 10,179 165 131 31,236 
-- / 150 7,115 114 149 30,754 
Cells were stimulated by antibody coated on plates at concentrations of either 10 uglml, to elicit maximal proliferative response, or 0.3 uglml. 
which was optimal for observing costimulatory effects of IL-2. After 48 h, cultures were pulsed with PH]thymidine as indicated in Experimental 
Procedures, and assayed by scintillation counting. Values represent average CPM from duplicate wells for each sample. 
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Figure 5. Peripheral Deletion of T Cells Following Immunization with 
SEB 
Mice were immunized with SEB, 50 Pg IP on day 1, followed by 25 
Pg IP on day 3. Lymph nodes were harvested on day 10 and analyzed 
by flow cytometry. The percentage of T cells (CD4 and CD8 positive) 
bearing either V88, which reacts with SEB, or the non-SEB-reactive 
Vb6 subset were quantitated. Symbols represent values for individual 
mice. The impaired deletion of Vf38+ T cells to SEB was statistically 
significant (p < 0.05, student’s t test). 
the expansion of cells at the prothymocyte and pre-6 cell 
stages, since a subtle defect in IL-2Ra-deficient mice 
could be compensated at later (or earlier) stages of devel- 
opment. 
Comparison of IL-2Ra-‘- and IL%- Phenotypes 
The phenotypes of mice that lack either IL-2Fia or IL-2 
share overlapping features. IL-e-deficient mice have no 
overt defect in normal T and 6 cell development, and are 
able to mount both cellular and humoral immune re- 
sponses in vivo (Schorle et al., 1991; Kundig et al., 1993). 
The anemia and bowel disease observed in IL-2Ra- 
deficient mice are similar to complications observed in 
IL-e-deficient mice (Sadlack et al., 1993). These similari- 
ties indicate that the immune regulatory effects exerted 
by IL-2Ra occur via signaling through the high affinity IL-2 
receptor. In this context, the tripartite apy complex is not 
replaceable by the low affinity 6~ receptor despite the abil- 
ity of this receptor to transduce signals in vitro (Nakamura 
et al., 1994; Nelson et al., 1994). 
The massive expansion of peripheral lymphoid tissue 
observed in IL-2Ra-deficient mice was not noted in several 
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studies of IL-2-j- mice (Kundig et al., 1993; Sadlack et al., 
1993; Schorle et al., 1991)‘ although one study reported 
a 3-fold expansion of lymph node cells in these mice (Sad- 
lack et al., 1994). This discrepancy could reflect subtle 
differences in genetic background, or potential differences 
in environmental exposures: for example, to commensal 
microorganisms, which are known to be required for the 
development of inflammatory bowel disease in IL-2-‘- mice 
(Sadlack et al., 1993). Alternatively, these differences 
could indicate that IL-2Ra may have functions in addition 
to regulating cellular sensitivity to IL-2. For example, IL- 
2Ra could have an additional ligand, or may modulate the 
signaling activity of other receptor chains in the absence 
of IL-2 binding. The latter possibility is suggested by the 
fact that IL-2Ra is expressed in large stoichiometric ex- 
cess relative to the IL-2Rb and IL-PRY chains on activated 
T cells, and may associate with the IL-2Rf3 chain in the 
absence of IL-2 (Grant et al., 1992). 
IL-2Ra Is a Negative Regulator of the Peripheral 
T Cell Compartment 
Despite constant stimulation by environmental antigens, 
the peripheral lymphoid compartment maintains a rel- 
atively constant size over time. In the T cell lineage, pe- 
ripheral homeostasis involves a linkage between prolifer- 
ative expansion and elimination of activated cells by 
programmed cell death (Rocha and von Boehmer, 1991; 
Kawabe and Ochi, 1991; Lenardo, 1991; Critchfield et al., 
1994; McHeyzer-Williams and Davis, 1995). This process 
is intimately related to the shaping of the immune reper- 
toire and the exclusion of autoreactive clones, which oc- 
curs in the periphery(Critchfield et al., 1994). The massive 
polyclonal expansion of lymphoid tissue in IL-2Ra-‘- mice 
suggests that IL-2Ra has a general role in maintaining this 
homeostatic balance, which could be altered by exagger- 
ated proliferation, impaired cell death, or both. Our data 
do not indicate that lymphocyte proliferation was overly 
active in IL-2Ra-deficient mice, since we did not see an 
increased fraction of lymphocytes in vivo with blast mor- 
phology or CD69 expression, or which were actively 
cycling. Moreover, T cell mitogenic responses were mark- 
edly depressed in vitro. The fact that steady-state esti- 
mates of proliferation were normal in the mutant mice indi- 
cates that IL-2Ra is not required to supply cell cycle 
progression signals in vivo, a function which is presumably 
supplied by lymphokines other than IL-2. 
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Figure 6. Serum lmmunoglobulin Determina- 
tions 
Serum from mice aged 8-12 weeks was ana- 
lyzed for the indicated immunoglobulin iso- 
types by ELISA. Symbols represent individual 
wild-type (squares), heterozygous (diamonds), 
and homozygous mutant mice (circles). 
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Figure 7. Older IL-2Ra Mutant Mice Develop 
Inflammatory Colitis 
(A) Normal colon from a wild-type littermate. 
(original magnification, 100 x at 91% reduc- 
tion). The epitheliat cells contain abundant pale 
mucin and the lamina propria contains few in- 
flammatory cells. 
(6) Colon from an affected IL-2Ra mutant 
mouse, demonstrating marked thickening of 
the mucosa, dense infiltration by lymphocytes 
and neutrophils, and loss of mucin in the epi- 
thelial cells. Focally, neutrophils invade individ- 
ual glands to form crypt abscesses (asterisks) 
(same magnification as [A]). 
(C) Crypt abscess in an IL-2Ra-deficient 
mouse. The epithelial cells lining the affected 
gland are severely damaged, and the gland is 
dilated (original magnification, 250 x at 91% 
reduction). Paraffin tissue sections were 
stained with hematoxolin and eosin. 
Our finding that deletion of SEB-reactive T cells was could result from a normal level of lymphocyte stimulation 
impaired in mice lacking IL-2Ra indicates that this chain from the environment in the setting of reduced elimination 
plays an important role in the regulation of activation- of these cells after activation. This scenario is supported 
induced T cell death in vivo. Thus, the expansion of by the findings that the accumulated lymphocytes were 
lymphoid tissue acquired as these mice reach adulthood polyclonal and that most of the T cells expressed high 
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levels of CD44, indicative of past activation. Defective acti- 
vation-induced cell death in IL-2Ra-deficient mice could 
also extend to autoreactive lymphocyte clones, potentially 
explaining the development of autoimmune disorders in 
these animals. IL-2 has previously been implicated in pro- 
moting activation-induced T cell death (Lenardo, 1991; 
Critchfield et al., 1994). Our data indicate that the regula- 
tion of cell death by IL-2 receptor signals is physiologically 
relevant, and may constitute the major function of these 
signals in vivo. 
Activation-induced cell death in lymphocytes is signaled 
by interaction between the Fas receptor and its ligand, 
both of which are up-regulated on Tcells following stimula- 
tion (Alderson et al., 1995; Brunner et al., 1995; Dhein et 
al., 1995; Ju et al., 1995). Mice (Nagata, 1994)or humans 
(Fisher et al., 1995; Rieux-Laucat et al., 1995) that are 
defective in this pathway develop massive expansion of 
lymphoid tissues and autoimmunity. However, the lym- 
phoid enlargement observed in the absence of Fas or Fas 
ligand is due to accumulation of an abnormal population 
of CD3+CD4-CD8- lymphocytes (Nagata, 1994; Fisher et 
al., 1995), which were not seen in IL-2Ra-‘- mice. More- 
over, the spectrum of autoimmune disease in both mice 
and humans with these mutations is characterized by 
prominent vasculitis and antigen-antibody complex de- 
posits, which contrasts with the predominance of inflam- 
matory bowel disease in mice lacking either IL-2 or IL-2Ra. 
These differences indicate that IL-2 receptor signals are 
not likely to be direct regulators of Fas and Fas ligand 
activity, a hypothesis supported by preliminary evidence 
that surface expression of these molecules is unaltered 
in mice lacking either IL-2 or IL-2Ra (D. M. W., A. M., and 
F. W. A., unpublished data). More likely, Fas-dependent 
cell death is controlled by several regulatory signals, one 
of which is dependent on IL-2Ra. 
The dynamic regulation of the immune repertoire in- 
volves activation of T and B cells by antigen in a complex 
milieu of intercellular and soluble signals, and engenders 
both the maintenance of self-tolerance and a balanced 
outcome of clonal expansion and cell death. Our observa- 
tions indicate that IL-2Ra, which is itself a tightly controlled 
component of the activation program in both T and B cells, 
has a general regulatory function in maintaining the overall 
size of the immune system and adjusting its composition 
to avoid certain types of autoimmunity. 
Experimental Procedures 
Gene Targeting and Generation of IL-2Ra-‘- Mice 
An IL-2Ra cDNA probe (gift of R. N. Germain) was used 10 isolate and 
map genomic phage clones encompassing the indicated region of the 
IL-2Ra locus (Figure 1A) from a mouse 129 strain genomic library 
(Stratagene, Torrey Pines, California). ES cells (Jl line, provided by 
R. Jaenisch) were grown and transfected as described (Li et al., 1992). 
Neomycin-resistant colonies were selected with ES media containing 
G418 (0.4 mglml) and screened by Southern blotting for homologous 
recombination events. Two independent ES cell clones containing the 
targeted mutation of IL-2Ra were injected into C57BU6 blastocysts. 
Resulting chimeras were bred with C57BU6 mice, and both clones 
transmitted efficiently into the germline. 
Flow Cytometric Analysis 
Single-ceil suspensions of lymphoid tissues were prepared and 
stained with monoclonal antibodies as described (Coligan et al., 1991). 
Monoclonal antibodies lo the indicated surface markers, including IL- 
2Ra (clone 7D4). were obtained from Pharmingen (San Diego, Califor- 
nia). Biotinylated antibody stains were developed with streptavidin- 
cychrome (Pharmingen). Cell cycle analysis was performed on lymph 
node or spleen cell suspensions stained with fluorescein isothiocya- 
nate (FITC)-conjugated antibodies to either CD3 or 8220, followed by 
fixation and staining with propidium iodide as described (Coligan et 
al., 1991). Analyses were performed on a FACScan instrument (Bec- 
ton-Dickinson, Mountain View, California). 
Proliferation Assays 
Lymph node T cells were purified by incubation with magnetic beads 
coated with sheep anti-mouse immunoglobulin antibodies (Dynal, 
Oslo, Norway) and separated with a magnet as recommended by the 
manufacturer. Flow cytometric analysis of purified cells indicated that 
90%-95% were T cells. Proliferation assays were performed in dupli- 
cate in 96-well plates, which were precoated as indicated with anti- 
CD3& antibodies (clone 2C11, Pharmingen, San Diego, California) for 
2hrat37OC. Lymphocytes& x 10”)wereculturedinO.l mlRPMI-1640 
medium supplemented with 10% fetal calf serum (GIBCO), glutamine, 
pyruvate, penicillin, and streptomycin. Recombinant murine IL-2 was 
purchased from Pharmingen (San Diego, California). After 46 hr, cul- 
tures were pulsed for 14 hr with 0.1 pCi [3H]thymidine prior lo harvest 
and scintillation counting. Proliferation of B cells was assessed as 
described (Bottaro et al., 1994). 
SEE Immunization 
Mice (5 weeks old) were immunized with either phosphate-buffered 
saline or SEB (Sigma, St. Louis, Missouri) 50 pg IP on day 1, followed 
by 25 bg IP on day 3. Mice were sacrificed on day IO and lymph 
node suspensions were analyzed by flow cytometry using antibodies 
to CD4-FITC, CD&phycoerythrin (PE), and either VBG-biotin or 
Vp8.1 ,V@.P-biotin, followed bystreptavidin-cychrome (Pharmingen, 
San Diego, California). 
Serum lmmunoglobulin Determinations 
Serum was obtained from 8- to 12-week-old mice and frozen at -8OOC 
until analysis. Antigen capture ELISA was performed as described 
(Burstein et al., 1991), using reagents purchased from either Southern 
Biotechnology or Zymed Laboratories. 
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Note Added in Proof 
IL-2Ra chain-deficient mice have been deposited in the Induced Mu- 
tant Resource at the Jackson Laboratory (Bar Harbor, Maine). The 
strain designation is 112ratm1Dw. 
